Martin Schreiber

8.5k total citations · 2 hit papers
127 papers, 6.6k citations indexed

About

Martin Schreiber is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Martin Schreiber has authored 127 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 25 papers in Oncology and 17 papers in Genetics. Recurrent topics in Martin Schreiber's work include Trauma, Hemostasis, Coagulopathy, Resuscitation (11 papers), Trauma and Emergency Care Studies (10 papers) and Synthesis and Properties of Aromatic Compounds (8 papers). Martin Schreiber is often cited by papers focused on Trauma, Hemostasis, Coagulopathy, Resuscitation (11 papers), Trauma and Emergency Care Studies (10 papers) and Synthesis and Properties of Aromatic Compounds (8 papers). Martin Schreiber collaborates with scholars based in Austria, United States and Germany. Martin Schreiber's co-authors include Erwin F. Wagner, Hartmut Beug, Michael Karin, Brigitta Dampier, Andreas Eger, Roland Foisner, Fabrice Piu, Andrea Kolbus, Susanne Oehler and Geert Berx and has published in prestigious journals such as Nature, Cell and Journal of the American Chemical Society.

In The Last Decade

Martin Schreiber

118 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells

2005 655 citations Brigitta Dampier, Martin Schreiber et al. profile →
Regulation of cancer cell migration and bone metastasis by RANKL

2006 601 citations Martin Schreiber et al. profile →

Peers

Countries citing papers authored by Martin Schreiber

Since Specialization

Citations

This map shows the geographic impact of Martin Schreiber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Schreiber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Schreiber more than expected).

Fields of papers citing papers by Martin Schreiber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Schreiber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Schreiber. The network helps show where Martin Schreiber may publish in the future.

Co-authorship network of co-authors of Martin Schreiber

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Schreiber. A scholar is included among the top collaborators of Martin Schreiber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Schreiber. Martin Schreiber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis of Poly(Itaconate)s With High Monomer Conversion Applying Emulsion Polymerization 2025 ·Journal of Polymer Science ·(unknown), Nico Ueberschaar, Martin Schreiber, (unknown), Stefan Zechel, Martin D. Hager	2
2	Early achievement of hemostasis defined by transfusion velocity: A possible mechanism for whole blood survival benefit 2025 ·The Journal of Trauma: Injury, Infection, and Critical Care ·Amanda M. Chipman, James F. Luther, Francis X. Guyette, Bryan A. Cotton, Jeremy W. Cannon, Martin Schreiber, Ernest E. Moore, Nicholas Namias, Joseph P. Minei, Mark H. Yazer, Laura Vincent, (unknown), Vikas Agarwal, Joshua B. Brown, Christine M. Leeper, Matthew D. Neal, Raquel M. Forsythe, Stephen R. Wisniewski, Jason L. Sperry, (unknown)	0
3	The rs2046210 Polymorphism Is Associated with Endometriosis Risk and Elevated Estrogen Receptor 1 Expression in the Eutopic Endometrium of Women with the Disease 2024 ·Biomedicines ·Katharina Proestling, Martin Schreiber, (unknown), Quanah J. Hudson, H Husslein, Lorenz Kuessel, (unknown), René Wenzl, Iveta Yotova	0
4	Aberrant DNA Methylation, Expression, and Occurrence of Transcript Variants of the ABC Transporter ABCA7 in Breast Cancer 2023 ·Cells ·(unknown), (unknown), (unknown), (unknown), Lukas Schmidt, (unknown), (unknown), Martin Schreiber, (unknown), Christine Pirker, Georg Pfeiler, Stefan Hacker, Werner Haslik, Dietmar Pils, Andrea Bileck, Christopher Gerner, Samuel M. Meier, Petra Heffeter, Margit Cichna‐Markl	6
5	Association of the Telomerase Reverse Transcriptase rs10069690 Polymorphism with the Risk, Age at Onset and Prognosis of Triple Negative Breast Cancer 2023 ·International Journal of Molecular Sciences ·Karin Zins, (unknown), (unknown), (unknown), Dietmar Abraham, Martin Schreiber	7
6	Discrimination between 34 of 36 Possible Combinations of Three C>T SNP Genotypes in the MGMT Promoter by High Resolution Melting Analysis Coupled with Pyrosequencing Using A Single Primer Set 2021 ·International Journal of Molecular Sciences ·(unknown), Christine Pirker, (unknown), Martin Schreiber, Petra Heffeter, Georg Pfeiler, Stefan Hacker, Werner Haslik, Sabine Spiegl‐Kreinecker, Margit Cichna‐Markl	3
7	The effect of hemorrhage control adjuncts on outcome in severe pelvic fracture: A multi-institutional study 2019 ·The Journal of Trauma: Injury, Infection, and Critical Care ·Juan Duchesne, Todd W. Costantini, Mansoor Khan, Ethan Taub, Peter Rhee, Bryan C. Morse, Nicholas Namias, (unknown), (unknown), Dennis Y. Kim, (unknown), Jason L. Sperry, Vincent P. Anto, Robert D. Winfield, Martin Schreiber, (unknown), (unknown), Shariq Raza, Mark J. Seamon, Danielle Tatum	28
8	Elevated Aromatase (CYP19A1) Expression Is Associated with a Poor Survival of Patients with Estrogen Receptor Positive Breast Cancer 2018 ·Hormones and Cancer ·(unknown), (unknown), (unknown), (unknown), Martin Schreiber	20
9	The CMO Initiative. Peritoneal dialysis growth in the U.S. encounters unexpected hurdles. 2017 ·PubMed ·John Burkart, Martin Schreiber, Jeffrey L. Hymes, Brigitte Schiller	2
10	Analysis of the rs10046 Polymorphism of Aromatase (CYP19) in Premenopausal Onset of Human Breast Cancer 2014 ·International Journal of Molecular Sciences ·Karin Zins, (unknown), Christian Schneeberger, Dietmar Abraham, Martin Schreiber	17
11	Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome (OHSS)—a retrospective case–control study 2014 ·Journal of Ovarian Research ·Kazem Nouri, Peter Haslinger, (unknown), Michael Sator, Martin Schreiber, Christian Schneeberger, Detlef Pietrowski	18
12	Integration of the response to a dietary potassium load: a paleolithic perspective 2014 ·Nephrology Dialysis Transplantation ·K.S. Kamel, Martin Schreiber, M. L. Halperin	13
13	The L10P Polymorphism and Serum Levels of Transforming Growth Factor β1 in Human Breast Cancer 2013 ·International Journal of Molecular Sciences ·(unknown), Erika Márton, (unknown), (unknown), (unknown), (unknown), Martin Schreiber	22
14	Information System on Literature in the Field of ICT for Environmental Sustainability 2010 ·EnviroInfo ·Richard A. Lutz, (unknown), (unknown), Martin Schreiber	0
15	Biomarker discovery in breast cancer serum using 2‐D differential gel electrophoresis/ MALDI‐TOF/TOF and data validation by routine clinical assays 2006 ·Electrophoresis ·Honglei Huang, Taras Stasyk, Sandra Morandell, Hans Dieplinger, Gerda Falkensammer, Andrea Griesmacher, (unknown), Martin Schreiber, Isabel Feuerstein, Christian W. Huck, Guenther Stecher, Guenther K. Bonn, Lukas A. Huber	111
16	ILEI: A cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells 2006 ·Cancer Cell ·Thomas Waerner, (unknown), (unknown), (unknown), Annamaria Gal, Thomas Brabletz, Martin Schreiber, Martin Jechlinger, Hartmut Beug	150
17	Expression of HER2 and the Coamplified Genes GRB7 and MLN64 in Human Breast Cancer: Quantitative Real-time Reverse Transcription-PCR as a Diagnostic Alternative to Immunohistochemistry and Fluorescence In situ Hybridization 2005 ·Clinical Cancer Research ·Ursula Vinatzer, Brigitta Dampier, Berthold Streubel, Margit Pacher, Michael J. Seewald, Christian Stratowa, Klaus Kaserer, Martin Schreiber	82
18	Tissue-Wide Expression Profiling Using cDNA Subtraction and Microarrays to Identify Tumor-Specific Genes 2004 ·Cancer Research ·Stefan Amatschek, Ulrich Koenig, Herbert Auer, Peter Steinlein, Margit Pacher, (unknown), Gerhard Dekan, Sonja Vogl, E. Kubista, Karl‐Heinz Heider, Christian Stratowa, Martin Schreiber, Wolfgang Sommergruber	203
19	Negative regulation of p53 expression is an essential, rate-limiting function of Jun in the control of cell cycle progression 2000 ·Breast Cancer Research ·Martin Schreiber, Fabrice Piu, Andrea Kolbus, Axel Szabowski, Uta Möhle-Steinlein, J Tian, Michael Karin, Paul W. Angel, Erwin F. Wagner	1
20	Cell proliferation and cell cycle progression are not impaired in fibroblasts and ES cells lacking c-Fos. 1995 ·PubMed ·Sabine Brüsselbach, Uta Möhle-Steinlein, Zhiqin Wang, Martin Schreiber, Frances C. Lucibello, Rolf Müller, Erwin F. Wagner	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact